Consequently, we investigated 535 primary prostate cancer tumors for expression of PD-L1 in stromal and epithelial cells, as well as the expression of PD-1 and co-expression of PD-1 and CD8 in lymphocytes, and their associations with biochemical and clinical failure-free survival. Here, CD8A is linked to prostate carcinoma.